Dynamic release and clearance of circulating microparticles during cardiac stress

Circulation Research

Volumn 114, Issue 1, 2014, Pages 109-113

  Augustine, Daniel ^a   Ayers, Lisa V ^b   Lima, Eduardo ^a   Newton, Laura ^a   Lewandowski, Adam J ^a   Davis, Esther F ^a   Ferry, Berne ^b   Leeson, Paul ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

cell derived; dobutamine stress echocardiography; microparticles; vascular diseases

Indexed keywords

DOBUTAMINE; PROCOAGULANT;

ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY; ECHOCARDIOGRAPHY; ENDOTHELIAL MICROPARTICLE; ERYTHROCYTE; FLOW CYTOMETRY; GRANULOCYTE; HEART MUSCLE ISCHEMIA; HEART STRESS; HUMAN; MAJOR CLINICAL STUDY; MEMBRANE MICROPARTICLE; MEMBRANE VESICLE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY; VASCULAR DISEASE;

EID: 84892948500     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.301904     Document Type: Article

References (28)

1. Baron M, Boulanger CM, Staels B, Tailleux A. Cell-derived microparti-cles in atherosclerosis: biomarkers and targets for pharmacological modulation? J Cell Mol Med. 2012;16:1365-1376.
2. Andrews RK, Berndt MC. Microparticles facilitate neutrophil/platelet crosstalk. Blood. 2008;112:2174-2175.
3. Maruyama K, Kadono T, Morishita E. Plasma levels of platelet-derived microparticles are increased after anaerobic exercise in healthy subjects. J Atheroscler Thromb. 2012;19:585-587.
4. Chaar V, Romana M, Tripette J, Broquere C, Huisse MG, Hue O, Hardy-Dessources MD, Connes P. Effect of strenuous physical exercise on circulating cell-derived microparticles. Clin Hemorheol Microcirc. 2011;47:15-25.
5. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res. 2003;59:277-287.
6. Dignat-George F, Boulanger CM. The many faces of endothelial mic-roparticles. Arterioscler Thromb Vasc Biol. 2011;31:27-33.
7. Bulut D, Tüns H, Mügge A. CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease. Eur J Clin Invest. 2009;39:17-22.
8. Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H. Signifcance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratifcation for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol. 2009;54:601-608.
9. Ueba T, Nomura S, Inami N, Nishikawa T, Kajiwara M, Iwata R, Yamashita K. Plasma level of platelet-derived microparticles is associated with coronary heart disease risk score in healthy men. J Atheroscler Thromb. 2010;17:342-349.
10. Tushuizen ME, Diamant M, Sturk A, Nieuwland R. Cell-derived mic-roparticles in the pathogenesis of cardiovascular disease: friend or foe? Arterioscler Thromb Vasc Biol. 2011;31:4-9.
11. Bernal-Mizrachi L, Jy W, Fierro C, Macdonough R, Velazques HA, Purow J, Jimenez JJ, Horstman LL, Ferreira A, de Marchena E, Ahn YS. Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol. 2004;97:439-446.
12. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiogra-phy in detecting coronary artery disease. Am J Cardiol. 1992;69:1269-1273.
13. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, Voigt JU, Zamorano JL; European Association of Echocardiography. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008;9:415-437.
14. Ayers L, Kohler M, Harrison P, Sargent I, Dragovic R, Schaap M, Nieuwland R, Brooks SA, Ferry B. Measurement of circulating cell-derived microparticles by fow cytometry: sources of variability within the assay. Thromb Res. 2011;127:370-377.
15. Galloway MT, Paglieroni TG, Wun T, Arena FJ, Lewis WR. Platelet activation during dobutamine stress echocardiography. Am Heart J. 1998;135:888-900.
16. Ferreira AC, Peter AA, Mendez AJ, Jimenez JJ, Mauro LM, Chirinos JA, Ghany R, Virani S, Garcia S, Horstman LL, Purow J, Jy W, Ahn YS, de Marchena E. Postprandial hypertriglyceridemia increases circulating levels of endothelial cell microparticles. Circulation. 2004;110:3599-3603.
17. Flaumenhaft R. Formation and fate of platelet microparticles. Blood Cells Mol Dis. 2006;36:182-187.
18. Davila M, Amirkhosravi A, Coll E, Desai H, Robles L, Colon J, Baker CH, Francis JL. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost. 2008;6: 1517-1524.
19. Rand ML, Wang H, Bang KW, Packham MA, Freedman J. Rapid clearance of procoagulant platelet-derived microparticles from the circulation of rabbits. J Thromb Haemost. 2006;4:1621-1623.
20. Rank A, Nieuwland R, Crispin A, Grützner S, Iberer M, Toth B, Pihusch R. Clearance of platelet microparticles in vivo. Platelets. 2011;22: 111-116.
21. Jy W, Jimenez JJ, Mauro LM, Horstman LL, Cheng P, Ahn ER, Bidot CJ, Ahn YS. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation. J Thromb Haemost. 2005;3:1301-1308.
22. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct mic-roparticles in activation and apoptosis. Thromb Res. 2003;109:175-180.
23. Nozaki T, Sugiyama S, Sugamura K, Ohba K, Matsuzawa Y, Konishi M, Matsubara J, Akiyama E, Sumida H, Matsui K, Jinnouchi H, Ogawa H. Prognostic value of endothelial microparticles in patients with heart failure. Eur J Heart Fail. 2010;12:1223-1228.
24. Periard D, Boulanger CM, Eyer S, Amabile N, Pugin P, Gerschheimer C, Hayoz D. Are circulating endothelial-derived and platelet-derived mi-croparticles a pathogenic factor in the cisplatin-induced stroke? Stroke. 2007;38:1636-1638.
25. Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, He M, Yamada M, Suzuki S, Yanai M, Kurosawa S, Yamaya M, Kubo H. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility. Thorax. 2012;67:1067-1074.
26. Sinning JM, Losch J, Walenta K, Böhm M, Nickenig G, Werner N. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J. 2011;32:2034-2041.
27. Amabile N, Guérin AP, Tedgui A, Boulanger CM, London GM. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. Nephrol Dial Transplant. 2012;27: 1873-1880.
28. Ikonomidis I, Athanassopoulos G, Stamatelopoulos K, Lekakis J, Revela I, Venetsanou K, Marinou M, Monaco C, Cokkinos DV, Nihoyannopoulos P. Additive prognostic value of interleukin-6 at peak phase of dobutamine stress echocardiography in patients with coronary artery disease. A 6-year follow-up study. Am Heart J. 2008;156:269-276.